Registered entities
Interius BioTherapeutics, Inc.
Reg. No. 84-2963616United States
Innovation
18 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 515 times.
| Year | Filings |
|---|---|
| 2023 | 5 |
| 2024 | 13 |
| 2025 | 14 |
| 2026 | 10 |
Social engagement
Social engagement: 9K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include Fairmount Funds Management, Agent Capital, The Mark Foundation, Tellus BioVentures; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 44% |
| Private equity | 1 | 6% |
| Angel & family office | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 7 | 39% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
3 Jul 2025 · Research Assistant/Research Associate, Analytical Development · Philadelphia, Pennsylvania
Based on job postings tracked across public sources.